The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland
Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.
Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.
Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto
A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.
A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.
Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.
Cancer Research UK’s Drug Development Office has opened the first trial of a new type of leukaemia drug.
A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.